To download our documents

To receive OSE Immunotherapeutics’ latest news

Live stock price

OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris

Share price





Type of listing


Number of outstanding shares

18,527,401 shares as of 1st January 2023


Eligible to Long-Only Deferred Settlement Service

Financial calendar

This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).

27 April 2023

Annual financial results 2022

22 June 2023

General shareholders' meeting

27 September 2023

Half-year results 2023


Read more
Invest Securities
Jamila El Bougrini
Jonas Peciulis
Kepler Cheuvreux
Pierre-Alexandre Desir

Analyst reports

Read more
13/09/2023 Invest Securities - Un rappel médiatique qui fait du bien à Tedopi®
03/08/2023 EDISON - Operational Update
06/07/2023 EDISON - Regulatory Update

Regulated information

Read more
27/09/2023 Exercise of 2023 share subscription warrants at September 27, 2023
12/07/2023 Exercise of 2023 share subscription warrants at July 12, 2023

General shareholders' meetings

Read more

General Shareholders' Meeting 2023

All the documents below are in French (except the and "Voting form"

Financial information and publications

Read more
2023 Auditors's report on first-half 2023 financial report (in French)
2023 First-half 2023 financial report (in French)
2023 2022 Universal registration document